If modern medicine invented a single pill that could slash cardiovascular disease, blunt cognitive decline, lower systemic inflammation, and add a decade of vitality to your lifespan, pharmaceutical companies would charge $1,000 a month for it. Yet the most potent prescription…
In a study published in Discover Imaging, researchers at the University of Colorado Denver induced acute lung injury in mice with an intraperitoneal dose of lipopolysaccharide (LPS), then used specialized cyclic hydroxylamine probes to trap superoxide in blood, lung cells,…
A farming conference will return to Yorkshire in 2027 with a focus on collaboration. The 2027 Yorkshire Farming Conference, held at the Great Yorkshire Events Centre, aims to inspire fresh thinking in agriculture by showcasing successful examples of farmers working together to…
Your provider will consider ITP treatments based on your health, preferences and other factors Gloved medical hand holding vial of blood, next to magnifying glass over blood cells In adults, the rare blood disorder immune thrombocytopenia (ITP) occasionally resolves on…
AI use will surely increase exponentially, but much of that intelligence will move into people’s hands. Companies counting on keeping it centralised could become toast, and India should study what happened to earlier computing pioneers before buying its own toaster.
Experiments in lab-grown cells show process helps bacteria multiply Written by Michela Luciano, PhD | Oct. 20, 2026 A metabolic pathway shared by lung cells and bacteria may help explain two major features of lung disease in people with cystic fibrosis (CF): the…
WSFA Tuskegee University's Carver Genomics Center now open Puppy yoga to help rescue dogs in need Man scheduled to die by lethal injection Thursday
TUSKEGEE, Ala. (WSFA) - A project more than five years in the making officially reached the finish line in Macon County as Tuskegee University cut the ribbon on its new Carver Genomics Center. The $14 million facility marks a massive leap forward…
The review also highlights a less obvious property of these particles. In the tumor microenvironment, platelet-derived microparticles can harbor antitumor functions, meaning their effects on cancer are not exclusively harmful. Building on that biological groundwork, the review turns to nanotechnology.
A 2026 paper in OncoTargets and Therapy summarized pMMR tumors' cold landscape starkly: pMMR tumors exhibit "primary resistance to single-agent ICIs, their 'cold' immunological landscape posing a formidable challenge," and noted that no immunotherapy has yet been approved for MSS/pMMR…
Labs, patents and what's next.
An article joins this feed when it matches these terms. Each one is also a search of its own.